These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33960251)

  • 1. Facile synthesis of PEI-based crystalline templated mesoporous silica with molecular chirality for improved oral delivery of the poorly water-soluble drug.
    Xin W; Wang Y; Bian Y; Lin J; Weng W; Zhao X; Gou K; Guo X; Li H
    Drug Deliv; 2021 Dec; 28(1):894-905. PubMed ID: 33960251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine.
    Li H; Li H; Wei C; Ke J; Li J; Xu L; Liu H; YangYang ; Li S; Yang M
    Eur J Pharm Sci; 2018 May; 117():321-330. PubMed ID: 29530545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomimetic Synthesis and Evaluation of Interconnected Bimodal Mesostructured MSF@Poly(Ethyleneimine)s for Improved Drug Loading and Oral Adsorption of the Poorly Water-Soluble Drug, Ibuprofen.
    Xin W; Wang Y; Guo X; Gou K; Li J; Li S; Zhao L; Li H
    Int J Nanomedicine; 2020; 15():7451-7468. PubMed ID: 33116481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.
    Guo Y; Gou K; Yang B; Wang Y; Pu X; Li S; Li H
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31575047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile synthesis of functionalized ionic surfactant templated mesoporous silica for incorporation of poorly water-soluble drug.
    Li J; Xu L; Yang B; Wang H; Bao Z; Pan W; Li S
    Int J Pharm; 2015 Aug; 492(1-2):191-8. PubMed ID: 26163764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility.
    Hu B; Wang J; Li J; Li S; Li H
    Int J Nanomedicine; 2020; 15():601-618. PubMed ID: 32099354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pore size of three-dimensionally ordered macroporous chitosan-silica matrix on solubility, drug release, and oral bioavailability of loaded-nimodipine.
    Gao Y; Xie Y; Sun H; Zhao Q; Zheng X; Wang S; Jiang T
    Drug Dev Ind Pharm; 2016; 42(3):464-72. PubMed ID: 26507935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ε-benzyloxycarbonyl-L-lysine)-grafted branched polyethylenimine as efficient nanocarriers for indomethacin with enhanced oral bioavailability and anti-inflammatory efficacy.
    Lu C; Li X; Xia W; Lu S; Luo H; Ye D; Zhang Y; Liu D
    Acta Biomater; 2017 Feb; 49():434-443. PubMed ID: 27867110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiral Nanosilica Drug Delivery Systems Stereoselectively Interacted with the Intestinal Mucosa to Improve the Oral Adsorption of Insoluble Drugs.
    Chen X; Cheng Y; Pan Q; Wu L; Hao X; Bao Z; Li X; Yang M; Luo Q; Li H
    ACS Nano; 2023 Feb; 17(4):3705-3722. PubMed ID: 36787639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and preparation of mesoporous silica carriers with chiral structures for drug release differentiation.
    Wang Y; Li W; Liu T; Xu L; Guo Y; Ke J; Li S; Li H
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109737. PubMed ID: 31349514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
    Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S
    J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of amino-modified chiral mesoporous silica nanoparticles in delivering indometacin.
    Li J; Guo Y; Li H; Shang L; Li S
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1085-1094. PubMed ID: 28776393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral mesoporous silica synthesized by a facile strategy for loading and releasing poorly water-soluble drug.
    Gao Z; Lv X; Fu Y; Zang X; Sun Y; Li S; Zhang H; Qiao S; Wang L; Sun Y
    Drug Dev Ind Pharm; 2020 Jul; 46(7):1177-1184. PubMed ID: 32538184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic synthesized chiral mesoporous silica: Structures and controlled release functions as drug carrier.
    Li J; Xu L; Yang B; Bao Z; Pan W; Li S
    Mater Sci Eng C Mater Biol Appl; 2015 Oct; 55():367-72. PubMed ID: 26117767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant properties of probucol released from mesoporous silica.
    Lau M; Giri K; Garcia-Bennett AE
    Eur J Pharm Sci; 2019 Oct; 138():105038. PubMed ID: 31398394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability.
    Teng Z; Yu M; Ding Y; Zhang H; Shen Y; Jiang M; Liu P; Opoku-Damoah Y; Webster TJ; Zhou J
    Int J Nanomedicine; 2019; 14():119-133. PubMed ID: 30613141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.